Orientador: Giselle Zenker Justo / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-18T14:42:19Z (GMT). No. of bitstreams: 1 Silva_RodrigoAugustoda_D.pdf: 6436030 bytes, checksum: 9f8fa7c9b01f00bc5d2d2396d4099a1e (MD5) Previous issue date: 2011 / Resumo: A epiderme é constantemente confrontada por inúmeros agentes estressores. Variações na umidade ou exposição à radiação ultravioleta afetam o balanço osmótico e o estado redox celular alterando, assim, as características fisiológicas da pele. Em resposta aos diferentes estímulos os queratinócitos ativam vias distintas de sinalização. Portanto, o balanço entre as vias de sobrevivência e morte determina o destino celular. A fim de se determinar possíveis alvos moleculares associados a morte e sobrevivência de queratinócitos, vias de sinalização celular disparadas pela exposição ao choque hiperosmótico e estresse oxidativo foram investigadas em células HaCaT tratadas com sorbitol e peróxido de hidrogênio (H2O2) respectivamente. Os resultados obtidos neste estudo demonstraram que, em ambos os modelos, a redução da viabilidade celular dependeu da dose e do tempo de exposição ao agente extressor, apresentando valores de IC50 de aproximadamente 1 mol/L de sorbitol e 2 mmol/L de H2O2 após 2 e 4 h de exposição respectivamente. Os danos causados foram irreversíveis e estão associados à ativação da via intrínseca de morte celular apoptótica, acompanhada de perda da integridade da membrana lisossomal, extravasamento de catepsina B para o citosol e alterações morfológicas atípicas no citoesqueleto, principalmente no arranjo dos filamentos de actina. A investigação do status de funcionamento de proteínas quinases ativadas por mitógenos (MAPKs) e do estado redox celular indicou que esses eventos foram mediados por espécies reativas de oxigênio e pela ação da quinase c-Jun N-terminal (JNK). Adicionalmente, a exposição dos queratinócitos aos diferentes estímulos estressores foi acompanhada de ativação da proteína tirosina fosfatase de baixa massa molecular (LMWPTP), cuja relevância nos estudos de biologia celular aumentou nos últimos anos. A LMWPTP atua em importantes vias de sinalização que estão associadas à sobrevivência e morte celular. Cientificamente, este estudo é pioneiro ao demonstrar alterações no citoesqueleto e ação de proteínas quinases e fosfatases nos mecanismos que determinam o destino de queratinócitos expostos ao choque hiperosmótico e ao estresse oxidativo. De fato, o melhor conhecimento da relação entre as vias de sobrevivência e morte celular em queratinócitos é fundamental para promover o desenvolvimento de novas estratégias terapêuticas aplicadas às doenças dermatológicas. Desta maneira, o presente trabalho apresenta resultados inéditos, contribuindo no conhecimento da biologia dos queratinócitos e com sua aplicação no desenvolvimento da terapia dermatológica / Abstract: The epidermis is constantly confronted with multiple environmental stressors. Changes in humidity or exposition to UV radiation affect the redox state and osmotic balance, modifying the physiological characteristics of the skin. In response to different stresses, epidermal keratinocytes can activate distinct signaling pathways and the balance between death and life signals will determine the cell fate, leading to programmed cell death or cell survival. In order to determine the possible molecular targets associated to death and survival of keratinocytes, the signaling pathways activated by the exposition of HaCaT cells to sorbitol (hyperosmotic shock) and H2O2 (oxidative stress) were investigated. The results showed that in both models the reduction in cellular viability was time and dose-dependent, displaying IC50 values of 1 mol/L for sorbitol and 2 mmol/L for H2O2 after 2 and 4 h of exposition to the stressors, respectively. The damages caused by the stressors were irreversible and associated to the induction of the intrinsic apoptotic pathway, accompanied by the loss of lisosomal membrane integrity, release of cathepsin B to cytosol and atypical morphological alterations in cytoskeleton, particularly in the arrangement of actin filaments. Analysis of the functional status of mitogen-activated protein kinases (MAPKs) and the cellular redox state showed that such events were mediated by reactive oxygen species and occurred through c-Jun N-terminal kinase (JNK) activation. Additionally, exposure of keratinocytes to the different stress inducers was followed by low molecular weight tyrosine protein phosphatase (LMWPTP) activation, which is responsible for the regulation of important signaling pathways associated to cell survival and death. It is important to highlight the novelty of these results showing alterations in the cytoskeleton and the action of protein kinases and phosphatases during exposure of keratinocytes to hyperosmotic and oxidative stresses. In fact, the development of more efficacious therapies against skin diseases depends on the establishment of the relationships between the survival and death signaling pathways in keratinocytes. In this direction, this work contributes to a better understanding of the keratinocyte biology and the improvement of traditional dermatological therapies / Doutorado / Bioquimica / Doutor em Biologia Funcional e Molecular

Orientadores: João Agostinho Machado Neto, Sara Teresinha Olalla Saad / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-26T20:37:02Z (GMT). No. of bitstreams: 1 MachadoNeto_JoaoAgostinho_D.pdf: 13204649 bytes, checksum: a00ab26c9097cb10817c14fe2bdb2356 (MD5) Previous issue date: 2015 / Resumo: A identificação de genes/proteínas diferencialmente expressos em neoplasias hematológicas e a investigação funcional destas proteínas no fenótipo neoplásico são essenciais para o entendimento da biologia da doença. ANKHD1 é altamente expressa em células de leucemia aguda e tem potencial para regular vários processos celulares através de seus domínios de repetição de anquirina. Nosso grupo de pesquisa havia previamente identificado a interação entre ANKHD1 e SIVA através de ensaio de duplo híbrido. Outras proteínas potencialmente relacionadas à ANKHD1 que foram de interesse deste trabalho foram a Stathmin 1 que interage com SIVA e a YAP1 que interage com ANKHD1 em células não hematológicas. O objetivo principal do presente trabalho foi investigar a participação funcional de ANKHD1 e proteínas relacionadas em neoplasias hematológicas. Utilizamos modelos de linhagens leucêmicas humanas e células hematopoéticas primárias provenientes de indivíduos normais (n=52) e de pacientes com diagnóstico de síndrome mielodisplásica (SMD; n=65), neoplasia mieloproliferativa (NMP; n=82), leucemia mieloide aguda (LMA; n=60) e leucemia linfoide aguda (LLA; n=19). Técnicas para avaliação de expressão gênica (qPCR), expressão e interação proteica (western blotting), ensaios funcionais de migração (ensaio transwell), proliferação (MTT e clonogenicidade in vitro, formação de tumor in vivo) e apoptose (Anexina V/IP, TUNEL), e inibição de proteínas de interesse através do uso de inibidores farmacológicos ou ferramentas de terapia gênica foram utilizados. A interação entre ANKHD1 e SIVA foi confirmada por ensaios de coimunoprecipitação. Em linhagens celulares leucêmicas U937 e Jurkat, o silenciamento de ANKHD1 reduziu a proliferação celular, migração e o crescimento tumoral, enquanto que a inibição de SIVA aumentou a migração e o crescimento tumoral e reduziu a sensibilidade à apoptose induzida por radiação UV de células U937. A inibição de ANKHD1 reduziu a atividade de Stathmin 1 e a interação entre SIVA/Stathmin 1. Grande parte das linhagens leucêmicas e amostras primárias de pacientes com neoplasias hematológicas não apresentou a expressão de YAP1, e o silenciamento de ANKHD1 não modulou a atividade de YAP1 em células U937. A expressão de Stathmin 1 foi significativamente elevada em amostras de células hematopoéticas de pacientes com neoplasisa hematológicas (SMD AREB-1/AREB-2, LMA, LLA e mielofibrose primária) quando comparada às amostras de doadores saudáveis. O silenciamento de Stathmin 1 reduziu a proliferação celular e clonogenicidade em células leucêmicas U937, Namalwa e células HEL JAK2V617F. Especificamente em células HEL JAK2V617F, a inibição de Stathmin 1 ou o tratamento com o agente estabilizador de microtúbulos paclitaxel teve um efeito potencializador ao tratamento com ruxolitinib, inibidor de JAK1/2, na indução de apoptose. Em conclusão, propomos que a ANKHD1 participa do fenótipo neoplásico de células leucêmicas através de sua interação com SIVA, inibição de SIVA e ativação de Stathmin 1. Os nossos resultados indicam que a função de ANKHD1 na leucemogênese independe de sua interação com YAP1. Em células humanas com ativação constitutiva da via JAK2/STAT, identificamos a relevância funcional da participação de Stathmin 1 no fenótipo neoplásico / Abstract: The identification of genes/proteins differentially expressed in hematopoietic neoplasms and the functional investigation of these proteins in the neoplastic phenotype are essential for the understanding of disease biology. ANKHD1 is highly expressed in acute leukemia cells and has a potential role in regulating many cellular processes through its ankyrin repeat domains. Our research group has previously identified the interaction between ANKHD1 and SIVA through two-hybrid assay. Other proteins potentially related to ANKHD1 that were of interest of this research are Stathmin 1 that interacts with SIVA, and YAP1 that interacts with ANKHD1 in non hematologic cells. The aim of this study was to investigate the functional role of ANKHD1 and its related-proteins in hematologic malignancies. We used human leukemia cell lines and primary hematopoietic cells from healthy donors (n=52) and patients with myelodysplastic syndromes (MDS; n=65), myeloproliferative neoplasms (MPN; n=82), acute myeloid leukemia (AML; n=60) and acute lymphoid leukemia (ALL; n=19). Techniques for the evaluation of gene expression (qPCR), protein expression and interaction (western blotting), functional assays of migration (transwell assay), proliferation (in vitro MTT and clonogenicity, in vivo tumor formation) and apoptosis (Annexin V/PI, TUNEL), and inhibition of proteins of interest through pharmacologic agents or gene therapy tools were used. The interaction between ANKHD1 and SIVA was confirmed by co-immunoprecipitation assays. In leukemia cell lines U937 and Jurkat, ANKHD1 silencing reduced cell proliferation, migration and tumor growth, while SIVA inhibition increased migration and tumor growth, and reduced sensitivity to UV-induced apoptosis of U937 cells. Inhibition of ANKHD1 reduced Stathmin 1 activity and the interaction between SIVA/Stathmin 1. A large proportion of leukemia cell lines and primary samples from patients with hematologic malignancies did not present YAP1 expression, and ANKHD1 silencing did not modulate YAP1 activity in U937 cells. Stathmin 1 expression was significantly higher in primary hematopoietic cells from patients with hematological malignancies (MDS RAEB-1/RAEB-2, AML, ALL and primary myelofibrosis) compared to samples from healthy donors. Stathmin 1 silencing reduced cell proliferation and clonogenicity of U937 and Namalwa leukemia cells, and HEL JAK2V617F cells. Specifically in HEL JAK2V617F cells, Stathmin 1 silencing or treatment with the microtubule-stabilizing agent paclitaxel had a potentiating effect to treatment with the JAK1/2 inhibitor ruxolitinib on apoptosis induction. In conclusion, we propose that ANKHD1 participates in the leukemia phenotype through its interaction with SIVA, SIVA inhibition, and Stathmin 1 activation. Our results indicate that ANKHD1 plays a role in leukemogenesis independently of its interaction with YAP1. In human cells with a constitutive activation of the JAK2/STAT pathway, we identified the relevant role of Stathmin 1 in the malignant phenotype / Doutorado / Clinica Medica / Doutor em Clínica Médica

Les bactéries ont besoin d’adapter leur cycle cellulaire et leur taux de croissance aux changements environnementaux et nutritionnels. L’initiation de la réplication est ainsi strictement coordonnée aux autres processus cellulaire afin de transmettre un chromosome conforme. Chez B. subtilis, bactérie modèle des Gram⁺, la protéine YabA joue un rôle majeur en réprimant l’initiation de la réplication, ceci en formant un complexe avec la protéine initiatrice DnaA et la clamp polymérase DnaN. YabA interagit en outre avec d’autres protéines partenaires et serait donc multifonctionnelle. Sa structure 3D révèle une architecture en deux domaines: Un domaine N-terminal adoptant un repliement de type superhélice et un domaine C-terminal globulaire structuré autour d’un atome de Zinc. In vivo, YabA est un tétramère par interaction entre les superhélices, connecté aux domaines C-terminaux monomériques par une séquence déstructurée hyper flexible. YabA serait un hub structural interagissant simultanément avec plusieurs protéines et constituerait une plate-forme d’intégration entre différents signaux intracellulaires et l’initiation de la réplication. La phosphorylation est une modification post-traductionnelle modulant l’activité de nombreuses protéines en réponse à certains signaux cellulaires. Grâce à des expériences de phosphorylation in vitro et des analyses de spectrométrie de masse, nous avons montré que YabA est phosphorylée par la kinase de type Hanks YabT sur une thréonine, localisée dans la région flexible de liaison interdomaines. YabT est une kinase activée par l’ADN, exprimée en carence en glucose, en sporulation et en phase stationnaire. Nous avons construit des mutants phosphomimétique de YabA (yabA-T71D) et non phosphorylable (yabA-T71A) pour i) confirmer le rôle de T71 dans la phosphorylation et ii) réaliser des études fonctionnelles.Nous avons montré in vivo que la phosphorylation de YabA n’est pas impliquée dans l’initiation de la réplication, mais module des programmes de différenciation. La phosphorylation de YabA module inversement la sporulation et la formation de biofilm, ce qui souligne sa multifonctionnalité et son implication dans la signalisation cellulaire connectant l’initiation de la réplication et la différenciation. Nos résultats suggèrent que la phosphorylation YabT-dépendante de YabA affecte la différenciation en modulant le taux intracellulaire de Spo0A-P. En effet, la phosphorylation de YabA est corrélée à un taux élevé de Spo0A-P, ce qui stimule la sporulation et inhibe la formation de biofilm. Par ailleurs, nos expériences de chromatographie sur couche fine (TLC) et de “In-Gel” suggèrent que YabA possède une activité “ATP/GTPasique” atypique modulée par la phosphorylation de YabA sur T71. Nos analyses fonctionnelles révèlent un rôle potentiel de YabA sur des voies de signalisation dépendant du c-di-GMP, qui contrôle la formation du biofilm chez de nombreuses bactéries. Ces résultats suggèrent que YabA joue un rôle complexe pendant la différenciation en intégrant différentes voies de signalisation. Enfin, des analyses de LC-MS montrent que lorsqu’elle est surexprimée chez Escherichia coli, YabA est phosphorylée sur la tyrosine 90, qui appartient au domaine d’interaction C-terminal. Une étude double-hybride chez la levure montre que la phosphorylation de Y90 module l’interaction de YabA avec ses partenaires DnaA et DnaN. In vivo, la phosphorylation de Y90 module l’initiation de la réplication. La kinase impliquée n’a pas encore été identifiée, mais ces résultats suggèrent l’existence d’un contrôle de l’initiation de la réplication lié à la phosphorylation de YabA chez B. subtilis. En conclusion, l’ensemble de nos études suggèrent l’existence de différents niveaux de régulation de l’activité de YabA par phosphorylation sur thréonine et tyrosine. YabA, outre son rôle dans l’initiation de la réplication, joue un rôle majeur dans la différenciation de B. subtilis. / Upon environmental or nutritional changes, bacteria must adjust their cell cycle with their growth rate. Most particularly, DNA replication initiation events must be controlled and coordinated with cell physiology to ensure faithful chromosome inheritance. In Bacillus subtilis, a model of Gram-positive bacteria, YabA plays a major role in down regulating initiation replication through interaction with the initiator protein DnaA and the clamp polymerase DnaN. However, YabA is a structural hub protein able to interact with other protein partners, indicating it might be multifunctional. Through its unique overall tri-dimentional structure composed of N-terminal four helix-bundle tetramer connected to four monomeric C-terminal domains by a highly flexible linker, YabA is capable to physically interact with more than one protein at a time, thus providing a suitable platform to integrate intracellular signals to replication initiation. Phosphorylation is the most prevalent post translational modification that modulates protein activities in response to cellular signals. Using in vitro phosphorylation and mass spectrometry we demonstrated that YabA is phosphorylated by the Hanks-type serine/threonine kinase YabT at a threonine residue localized within the flexible inter-domain region. YabT is a kinase activated by DNA and up-regulated during glucose starvation, sporulation and stationary phase. We constructed YabA phosphomimetic (yab-AT71D) and non-phosohorylatable (yabA-T71A) mutants to (i) confirm the requirement of T71 for YabT-mediated phosphorylation in vitro and (ii) perform in vivo and in vitro functional studies.We show in vivo that the phosphorylation of YabA is not involved in initiation control, but rather modulates bacillus developmental processes. We found that YabA phosphorylation inversely regulates sporulation and biofilm formation highlighting the multifunctional role of YabA as well as its role in integrating physiological signals to connect chromosomal replication initiation control with cell development. Our results support a role of YabT-mediated phosphorylation of YabA in Bacillus subtilis life-style decision making through the modulation of Spo0A-P intracellular levels. We established that YabA phosphorylation correlates with high cellular levels of Spo0A-P, leading to sporulation stimulation and preventing biofilm formation. Additionally, thin layer chromatography (TLC) analysis and In-Gel assays showed that YabA possess an atypical "ATP / GTPase" activity. This unusual activity seems to be modulated by phosphorylation of the YabA T71 residue. Our functional analysis pointed to a potential role of YabA in the c-di-GMP signaling transduction pathway, known to regulate biofilm formation in many bacteria. This suggesting a complex regulatory role of YabA during development, involving signaling crosstalk. LC-MS analyzes showed that when overexpressed in Escherichia coli, YabA is phosphorylated on the residue Y90 in a YabT independent manner. Y90 belongs to the interaction C-terminal domain, which contacts DnaA and DnaN. We found that Y90 was involved YabA-mediated replication initiation control. We provided evidence that phosphorylation state of YabA at Y90 can potentially modulates a protein-interaction switch with its protein partners DnaA and DnaN in a yeast-two-hybrid-based assay. Although we did not identified a kinase responsible for the phosphorylation of YabA at Y90 in B. subtilis, this finding hint at the possibility of a YabA-mediated control of initiation modulated by phosphorylation in this bacteria. Thus, all of these in vitro and in vivo observations suggest the existence of different modes of regulation of YabA activity by phosphorylation, involving threonine and tyrosine residues. This study established that YabA, apart from its role during replication initiation, plays a key regulatory role in B. subtilis development.

The roles of Ca2 + and cAMP in olfactory transduction were explored using agents which affect calcium channels and second messenger systems. These agents were applied at certain calculated final concentrations onto olfactory epithelia of urethane-anesthetized frogs (Sana PiPlens) by two-sec aerosol spray. During extracellular recording, saturated vapors of isoamyl acetate were delivered every 100 sec in 0.3 sec pulses to produce an electroolfactogram (EOG). Inorganic cations that block inward calcium currents inhibit EOG responses with the following rank order: (La3+) > (Zn2+, Cd2+) > (Al3+, Ca2+, Sr2+) > (Co2+). Application of 7.5 mM La3+ eradicates £0G's, while Ba2+ (which can carry more current that Ca2+) initially produces significant enhancement (F=43.04, p<0.001, df=19). Magnesium ion has no effect on EOG's at 7.5 mM, while 1.5 X 10"4M Ca2+ is significantly inhibitory (F=5.74; p=0.0355; df=12). Control aerosol sprays of distilled water depress EOG's by an average of 5%. The organic calcium channel antagonists diltiazem and verapamil inhibit EOG's by 17% and 36X, respectively, at a concentration of 1.5 X 10~*M. Verapamil produces significant inhibition (F=17.17; p=0.002; df=ll) at 1.5 X 10" 5 M, while the 1,4-dihydropyridine calcium channel antagonists, nicardipine and nifedipine, do not inhibit beyond 1% DMSO controls. Several calmodulin antagonists decrease EOG's, but without correlation to their anti-calmodulin potency. Application of 1.5 X 10"*M chlorpromazine and N-(6-aminohexyl)-5-chloro-l-naphthalenesulfonamide inhibit EOG's by 31% and 27%, respectively, while trifluoperazine inhibits by 23%. Dibutyryl cAMP, a lipophilic mimic of cAMP, produces 54% inhibition at 1.5 X 10" *M. Dibutyryl cGMP, cGMP, cAMP, and adenosine all decrease EOG's by less than 15% compared to distilled water controls. Forskolin, a reversible activator of adenylate cyclase, inhibits EOG's by 57% at 1.5 X 10"5M, which is significant beyond the 1% DMSO controls (F=17.17; p=0.002; df=ll). These data support the hypothesis that Ca2+ participates in olfactory transduction. Calcium ions could serve as charge carriers, second messengers, or both. Cyclic AMP could be involved with the primary excitatory process or sensory adaptation, or both.

4 Abstract Mast cells are involved in variety of immunological processes, but they are mostly known for their role in allergy and asthma. As asthma and allergy are serious diseases with spreading tendency during last decades, mast cells are subject of intensive research. It is expected that studies of mast cell signalling pathways will contribute to our understanding of the nature of these diseases and help to design efficient treatment strategies. In an attempt to identify genes responsible for asthma disease, genome-wide screening methods have been currently applied. Using these methods, mutations in ORMDL3 (Orosomucoid1-like) protein were found out as a high risk asthma factor. ORMDL3 is a member of evolutionary conserved ORMDL family, comprising in mammals also of ORMDL1 and ORMDL2. Physiological function of these proteins is poorly understood and it has not been studied in mast cells. We decided to study the role of ORMDL proteins in mast cells. Lentiviral delivery system was optimised for generation of stable knock-downs (KD) of all three members of the ORMDL family in primary mast cells. The ORMDL gene expression was measured by improved qPCR (quantitative PCR) reaction buffers. We found that all ORMDL genes are expressed in mast cells in order ORMDL3 > ORMDL2 > ORMDL1. Next, we investigated the...

<p>Functioning as a “powerhouse”, the liver adapts to the metabolic needs of the body by maintaining a homeostatic balance. Prolactin receptor (PRLR) has been found to have a copious existence in the liver. Having established a well-defined role in both reproductive and endocrine systems, the role of this transmembrane protein in hepatocytes is yet to be elucidated. Due to its abundant nature, we hypothesized that PRLR is required for maintaining hepatic homeostasis and plays a role in liver diseases. To test this hypothesis, we defined two specific aims. The first was to explore whether PRLR loss-of-function affects liver structure and function in physiological conditions. The second was to determine whether PRLR is associated with liver pathology. We deleted the <i>Prlr</i> gene specifically in hepatocytes using a virus-based approach and evaluated liver function, transcriptome, and activities of downstream signaling molecules. Due to the absence of PRLR, we found that the urea cycle was disrupted, concomitant with excessive accumulation of urea in the blood; 133 genes exhibited differential expression, largely associated with hepatocyte structure, metabolism, and inflammation; and the activities of STAT3 and 5 were reduced. The results signify that PRLR indeed plays a homeostatic role in the liver. We also used <i>Prlr</i>^+/- mice to assess whether the loss of one allele of the <i>Prlr</i> gene alters maternal hepatic adaptations to pregnancy. As a result, in the pre-pregnancy state and during the first half of gestation, the expression of maternal hepatic PRLR protein was reduced approximately by half owing to <i>Prlr</i> insufficiency. However, during the second half of pregnancy, we observed compensatory upregulation of this molecule, leading to minimal interference in STAT 3 and 5 signaling and liver size. Contrary to a previous study in the breast and ovary, our results suggest that one allele of <i>Prlr</i> may be sufficient for the maternal liver to respond to this physiological stimulus (pregnancy). Furthermore, we examined the expression and activity of PRLR in fatty as well as cholestatic livers. Using a high fat diet, we induced non-alcoholic fatty liver disease (NAFLD). Strikingly and for the first time, we discovered that the short isoform of PRLR (PRLR-S) was completely inactivated in response to NAFLD, whereas the long isoform remained unchanged. This finding strongly suggests the involvement of PRLR-S in lipid metabolism. We also postulate that PRLR-L may be the major regulator of STAT signaling in the liver, consistent with other reports. Lastly, we induced extrahepatic cholestasis via bile duct ligation (BDL) in mice. As this liver disease progressed, the expression of both isoforms of PRLR generally declined and was surprisingly accompanied by increased STAT 3 and 5 activity. The data suggests that PRLR participates in this disease progression, with a disconnection between PRLR signaling and STAT proteins. Collectively, our preliminary studies suggest that PRLR signaling is required to maintain liver homeostasis and more prominently, is involved in liver diseases, especially NAFLD. These findings lay a foundation for our future studies.</p>

Calcium (Ca2+) is a universal second messenger controlling a wide variety of cellular reactions and adaptive responses. All the versatility of a Ca2+ signaling requires that the concentration of Ca2+ ions in the cytoplasm be highly regulated. Generation of Ca2+ mobilizing signals in cells involves regulation by multiple components controlling Ca2+ release from the internal stores, Ca2+ influx across the plasma membrane, elicitation of Ca2+ sensitive processes and finally the removal of Ca2+ from the cells. Inositol-1, 4, 5-trisphosphate receptors (IP3Rs) and ryandine receptors (RyRs) are the most studied Ca2+ release channels located on the internal stores. Previous studies have shown ryanodine receptors (RyRs) play a key role in the process of Ca2+ signaling participating in the oscillatory patterns of controlling the release of Ca2+ from ER and regulating the influx of Ca2+ by coupling with plasma Ca2+ channels. Although recent progress deciphered the behavior and function of RyRs in regulation of Ca2+ signal, it still remains mysterious in understanding the molecular mechanism of its regulation and its connection with plasma membrane Ca2+ channels in neuronal cells. Here this study aimed to utilized the most cutting-edge RNA interference techniques, along with well-characterized pharmacological regulators of RyRs, to better characterized the role of RyRs is our neuronal cell line model NG115-401L. Our first main goal of this project was to develop an effective protocol that could selectively knockout or knockdown expression levels of the RyR1 gene in NG115-401L cells. After testing different siRNA primers including their combination with different transfection reagent, the result shows a significant silencing effect to the RyR1 mRNA expression levels. In the second part of this study, we used a group of pharmacological agents with well-known regulatory actions on RyRs to characterize the functional roles of the RyRs expressed in NG115-401L cells. All four agonists which are ryanodine, caffeine, CMC and PCB 95 show their abilities to activate the RyRs, increase [Ca2+]iand induce the influx of Ca2+ via SOC. After transfected NG115-401L cells by siRNA, the Ca2+ release and influx signals were highly diminished suggesting RyR1 gene was successfully knocked down and the successfully knocked down and the Ca2+ mobilization mediated by RyR1 was decreased greatly. Finally in order to study the effects of the regulation of Ca2+ by RyR modulators and RyR gene knockdown on cell growth patterns and cell viability, the NG115-401L cells were exposed to various concentrations of RyR regulators and siRyR1 primer for different time periods. The siRNA transfection showed the least effect on cell growth, as compared with pharmacological agents that modulate RyR function. Considering we achieved high levels of gene knockdown and its low cytotoxity, our result suggests that siRNA silencing for RyRs may become a promising gene therapeutic target in the future.

Cell penetrating peptides (CPPs) are short sequences of amino acids that excel in crossing the cellular membrane without inducing cytotoxicity Interest in these peptides stem from their ability to be attached, and grant their penetrating properties to, a variety of cargo In this work we have combined the application of Confocal Raman Microscopy (CRM) and Atomic Force Microscopy for the first time to examine the interactions of unlabeled Transportan (TP), one of the most well studied CPPs, with mammalian cells CRM’s capability to discriminate control and treated cell groups was verified by principal component analysis (PCA) and linear discriminant analysis (LDA) and was 93-100% accurate We’ve determined that at a concentration of 20 μM TP enters cells through a non-endocytotic mechanism, has a high affinity for the cytoplasm and membranes, and results in a significant increase in cellular stiffness Our work provides the first direct evidence of this cell-stiffening phenomenon SFTI-1, the smallest member of a bicyclic, cysteine rich class of CPPs, was examined by CRM to determine the potential role of cyclic structure on cellular uptake The peptide, along with monocyclic and linear analogs was heavy isotope labeled and incubated with mammalian cells at numerous concentrations and timespans Our work is the first SFTI-1 uptake study forgoing the use of fluorophore conjugates, which have been linked to artificial cellular uptake We demonstrate herein the absence of any CRM detectable uptake, providing the first evidence that SFTI-1 may not be a CPP Finally, CRM was applied to the discrimination of normal and basal cell carcinoma cells obtained from the same donor The use of patient matched cells avoids the normal biochemical variations that exist among individuals, ensuring that discrimination is based solely on the cell’s diseased state CRM spectra, analyzed by PCA and LDA, were capable of spectral discrimination with 100% accuracy Major differences in the cancerous cells were an increase in lipids and nucleic acids, and an overall decrease in protein We also demonstrate an enhancement in Raman signal through the use of an aluminum foil substrate, providing a practical approach for measuring cells with thin morphologies / Includes bibliography / Dissertation (PhD)--Florida Atlantic University, 2016 / FAU Electronic Theses and Dissertations Collection

Solid tumors can hijack many of the same programs used in neurogenesis to enhance tumor growth and metastasis, thereby generating a plethora of neurogenesis-related molecules including semaphorins Among them, we have identified Semaphorin7A (SEMA7A) in breast cancer We first used to the DA-3 mammary tumor model to determine the effect of tumor-derived SEMA7A on immune cells We found that tumor-derived SEMA7A can modulate the production of proangiogenic chemokines CXCL2/MIP-2 and CXCL 1, and prometastatic MMP-9 in macrophages We next aimed to determine the expression and function of SEMA7A in mammary tumor cells We found that SEMA7A is highly expressed in both metastatic human and murine breast cancer cells We show that both TGF-β and hypoxia elicits the production of SEMA 7 A in mammary cells SEMA7 A shRNA silencing in 4T1 cells resulted in decreased mesenchymal markers MMP-3, MMP-13, Vimentin and TGF-β) SEMA7A silenced cells show increased stiffness with reduced migratory and proliferative potential In vivo, SEMA7A silenced 4T1 tumor bearing mice showed decreased tumor growth and metastasis Genetic ablation of host-derived SEMA7A synergized to further decrease the growth and metastasis of 4T1 cells Our findings suggest novel functional roles for SEMA7A in breast cancer and that SEMA7A could be a novel therapeutic target to limit tumor growth and metastasis / Includes bibliography / Dissertation (PhD)--Florida Atlantic University, 2016 / FAU Electronic Theses and Dissertations Collection

Hedgehog (Hh) est un morphogène secrété qui contrôle la croissance et la différentiation cellulaire chez les métazoaires. La dérégulation de son activité entraine des maladies développementales et de nombreux cancers chez l’adulte. Chez la drosophile, la transduction du signal Hh est initiée par la fixation de Hh sur son récepteur Patched (Ptc), conduisant à la stabilisation de la protéine membranaire Smoothened (Smo) et à l’activation du complexe de transduction composé de 5 protéines : les kinases Fused (Fu), PKA, GprK2, la kinésine Costal 2 (Cos2), et le facteur de transcription Cubitus Interruptus (Ci). Ma thèse a porté sur l’étude de la régulation et des interactions moléculaires entre les composants du complexe de transduction. Par des approches complémentaires, j’ai montré qu’en absence d’Hh, les protéines PKA et Fu interagissent du côté C-terminal de Ci, alors que la présence d’Hh induit leur relocalisation vers le domaine N-terminal de Ci. J’ai pu prouver que l’élément déclencheur de ce remaniement protéique est Smo. En présence d’Hh, Smo s’incorpore dans le complexe de transduction, conduisant à l’activation et au déplacement de Fu vers la région N-terminale de Ci. Ce remaniement entraine la phosphorylation et l’activation de Ci. Ma thèse révèle l’importance des changements de conformation au sein du complexe de transduction de la voie Hh. Le mécanisme de transduction étant conservé entre invertébrés et invertébrés, mon doctorat apporte des éléments de recherche pour mieux comprendre le fonctionnement normal et pathologique des cellules. / Hedgehog (Hh) is a secreted morphogen that controls growth and differentiation in both vertebrates and invertebrates. The dysregulation of its activity leads to severe developmental defects, and the onset of cancer in adults. In Drosophila, the Hh signal transduction is initiated by the binding of Hh to its receptor Patched (Ptc). This induces the stabilization of the transmembrane protein Smoothened (Smo) and the subsenquent activation of a transduction complex consisting of 5 proteins: the kinases Fused (Fu), PKA and Gprk2, the kinesin Costal2 (Cos2), and the transcription factor of the pathway Cubitus Interruptus (Ci). The aim of my thesis was to study the regulation and molecular interactions between the different components of the transduction complex. Thanks to complementary techniques, I have shown that in absence of Hh the proteins Fu and PKA interact in C-terminal part of Ci, whereas on the presence of Hh induces their relocalization toward the N-terminal domain of Ci. I have proved that the trigger element of this moving is Smo. In presence of Hh, Smo goes into transduction complex, allowing the activation and the moving of Fu toward N-terminal domain of Ci. This relocalization is responsible of Ci phosphorylation and activation. My thesis reveals the importance of conformational changes inside the transduction complex of Hh pathway. As the mechanism of transduction is conserved between species, my PhD provides research elements in order to better understand the normal and abnormal functioning of cells.